ETI Karle Clinical

ETI Karle Clinical is a Pan-Asian clinical research organization (CRO) headquartered in Bangalore, India, and is a subsidiary of the Karle Group. The company provides comprehensive clinical trial services, including site management, data management, and regulatory affairs, with a network of over 60 clinical trial sites. ETI Karle Clinical has historically collaborated with international biotechnology firms, such as Oramed Pharmaceuticals, to conduct Phase 2 clinical trials for innovative therapies like oral insulin. The firm utilizes advanced data management platforms such as Oracle Clinical and SAS to support its research activities. As of early 2026, the company's regulatory status is listed as struck off.